Several studies have recently highlighted that PD-L1 expression on innate immune cells such as macrophages, dendritic cells (DC) and monocytes, both in the TME and outside the tumor tissue, is essential for an effective PD-L1 and PD-1 blockade (5, 6). This evidence concerns the gene CD274 and neoplasm.